pembrolizumab,bca-101
bicara,merck
['bca101 ', 'scchn', 'pembro']
#esmo22 updates: bca101 (tgf- x egfr) pembrolizumab showed tolerated safety profile &amp; durable responses; stage 1 efficacy threshold achieved in dose expansion in scchn pts: keeping some hopes up in tgf-b space despite the failures
#solidtumors #immunooncology #cancer 
Course5i prides itself in enabling #LifeSciences organizations with insights, #analytics and #AI to drive strategic decisions. Enabling better health outcomes.